Jean-Marie Eveillard - First Eagle Investment Management,
Holding/activity history for Bio-Rad Laboratories Inc. (BIO)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 2,602,772 | 1.23 | Add 1.26% | 0.02 | $278.75 | $725,522,734 | SEC |
| 2025 Q4 | 2,570,473 | 1.37 | Add 1.99% | 0.03 | $302.99 | $778,827,760 | SEC |
| 2025 Q3 | 2,520,319 | 1.29 | Add 0.12% | <0.01 | $280.39 | $706,672,287 | SEC |
| 2025 Q2 | 2,517,313 | 1.18 | Add 60.73% | 0.45 | $241.32 | $607,478,077 | SEC |
| 2025 Q1 | 1,566,190 | 0.79 | Add 119.51% | 0.43 | $243.56 | $381,461,309 | SEC |
| 2024 Q4 | 713,505 | 0.53 | Add 0.07% | <0.01 | $328.51 | $234,393,527 | SEC |
| 2024 Q3 | 713,000 | 0.49 | Add 12.06% | 0.05 | $334.58 | $238,555,540 | SEC |
| 2024 Q2 | 636,275 | 0.39 | Add 32,296.89% | 0.39 | $273.11 | $173,773,065 | SEC |
| 2024 Q1 | 1,964 | <0.01 | Add 310.02% | <0.01 | $345.87 | $679,289 | SEC |
| 2023 Q4 | 479 | <0.01 | Add 4.59% | $322.89 | $154,664 | SEC | |
| 2023 Q3 | 458 | <0.01 | Add 139.79% | <0.01 | $358.45 | $164,170 | SEC |
| 2023 Q2 | 191 | <0.01 | Buy | <0.01 | $379.12 | $72,412 | SEC |